In:
The Journal of Clinical Hypertension, Wiley, Vol. 23, No. 7 ( 2021-07), p. 1363-1371
Abstract:
We evaluated the eligibility for baroreflex activation therapy (BAT) of 345 patients, attending the hypertension clinic at University Medicine Göttingen. Patients’ drug adherence was investigated by 75 toxicological analyses. Most common cause for a revoked BAT recommendation was blood pressure control by drug adjustment. Eventually, only less patients (7.8%) received a BAT system. Patients receiving a BAT recommendation showed specific characteristics and suffered numerous comorbidities, leading to a high cardiovascular risk, and therefore seem to greatly benefit from BAT implantation. 21.3% of patients showed non‐adherence, proving non‐adherence to be a relevant issue.
Type of Medium:
Online Resource
ISSN:
1524-6175
,
1751-7176
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
2058690-5
Bookmarklink